SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 6.36363636364 | 1.1 | 1.265 | 1.06 | 824436 | 1.16380529 | CS |
4 | 0.01 | 0.862068965517 | 1.16 | 1.265 | 1.055 | 735501 | 1.15007768 | CS |
12 | -0.19 | -13.9705882353 | 1.36 | 1.7 | 0.81 | 946812 | 1.28668441 | CS |
26 | 0.65 | 125 | 0.52 | 1.72 | 0.4986 | 1289737 | 1.18198112 | CS |
52 | -0.43 | -26.875 | 1.6 | 1.9 | 0.4986 | 949345 | 1.11208727 | CS |
156 | -7.63 | -86.7045454545 | 8.8 | 10.82 | 0.4986 | 475234 | 2.02305852 | CS |
260 | 1.017 | 664.705882353 | 0.153 | 19.38 | 0.11 | 1623688 | 2.87368349 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.